Latest epileptic disease Press Releases

As one of the leading press release distribution companies in the UK, we'll get your news in front of journalists and influencers quickly and cost-effectively

Submit your epileptic disease Press Release

5.0 Overall customer satisfaction

AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease
November 26, 2020

Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new ...